Purchases and Sales Made in Q1 2024 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q1 2024. The information is specifically focused on institutions that hold shares of ROCKET PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
M28 Capital Management LP
Stamford, CT |
SELL
|
- |
-138K- 26.3% |
$3.6M - $4.23M
|
386K
$4.14M
|
|
|
May 15, 2024
Q1 2024
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
SELL
|
- |
-146K- 3.61% |
$3.81M - $4.48M
|
3.89M
$41.8M
|
|
|
May 15, 2024
Q1 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-150K- 33.33% |
$3.92M - $4.61M
|
300K
$3.22M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-164K- 27.54% |
$4.28M - $5.03M
|
431K
$4.63M
|
|
|
May 14, 2024
Q1 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-282K- 73.61% |
$7.37M - $8.66M
|
101K
$1.08M
|
|
|
Apr 24, 2024
Q1 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-622K- 88.51% |
$16.3M - $19.1M
|
80.7K
$867K
|
|
|
May 15, 2024
Q1 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-694K- 40.38% |
$18.2M - $21.3M
|
1.03M
$11M
|